Cargando…
Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis()
PURPOSE: Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAr encephalitis) is an auto-immune disorder associated with the production of antibodies against NR1 and NR2 sub units of the NMDA receptor. Seizures in this population are reported in up to 50% of cases with status epilepticus being...
Autores principales: | Santoro, Jonathan D., Filippakis, Alexandra, Chitnis, Tanuja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657533/ https://www.ncbi.nlm.nih.gov/pubmed/31453565 http://dx.doi.org/10.1016/j.ebr.2019.100326 |
Ejemplares similares
-
Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015) -
Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
por: Monti, Giulia, et al.
Publicado: (2020) -
Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
por: Dinoto, Alessandro, et al.
Publicado: (2020) -
Refractory status epilepticus from NMDA receptor encephalitis successfully treated with an adjunctive ketogenic diet
por: Amer, Syed, et al.
Publicado: (2015) -
Anti-NMDA Receptor Antibody Encephalitis Presenting with Unilateral Non-convulsive Status Epilepticus in a Male Patient
por: Kim, Hyunjin, et al.
Publicado: (2015)